Information
-
Trademark
-
97315223
-
International Classifications
-
Filing Date
March 16, 2022
2 years ago
-
Transaction Date
April 24, 2023
a year ago
-
Status Date
April 22, 2023
a year ago
-
Location Date
April 22, 2023
a year ago
-
Status Code
602
-
Current Location
TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
Employee Name
BRYANT, ALEXANDRIA N
-
Attorney Docket Number
759874
Attorney Name
Mark J. Liss
Law Office Assigned Location Code
M40
-
Owners
Mark Drawing Code
4000
Mark Identification
REBONOX
Case File Statements
- GS0051: Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; injectable dermal fillers; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; biological preparations for medical or veterinary purposes for the treatment and prevention of neurological disorders and muscle dystonia; vaccines; medicated lotions for skin, hair, sunburn, face, body; implantable medicines for treating antiaging, neurological disorders and muscle dystonia; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; medicinal infusions for treating antiaging, neurological disorders and muscle dystonia
Case File Event Statements
-
4/24/2023 - a year ago
9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
4/22/2023 - a year ago
8 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Type: MAB2
-
4/22/2023 - a year ago
7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
1/4/2023 - 2 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
1/4/2023 - 2 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
1/4/2023 - 2 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/28/2022 - 2 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/22/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/19/2022 - 2 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP